WO2001028608A2 - Medicament dispenser - Google Patents

Medicament dispenser Download PDF

Info

Publication number
WO2001028608A2
WO2001028608A2 PCT/EP2000/009641 EP0009641W WO0128608A2 WO 2001028608 A2 WO2001028608 A2 WO 2001028608A2 EP 0009641 W EP0009641 W EP 0009641W WO 0128608 A2 WO0128608 A2 WO 0128608A2
Authority
WO
WIPO (PCT)
Prior art keywords
dispenser according
medicament dispenser
medicament
container
movable element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/009641
Other languages
French (fr)
Other versions
WO2001028608A3 (en
Inventor
Paul Kenneth Rand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to AT00966101T priority Critical patent/ATE462461T1/en
Priority to DE60044091T priority patent/DE60044091D1/en
Priority to JP2001531436A priority patent/JP2003512099A/en
Priority to EP00966101A priority patent/EP1221990B1/en
Priority to US10/110,957 priority patent/US7185648B1/en
Priority to AU76612/00A priority patent/AU7661200A/en
Publication of WO2001028608A2 publication Critical patent/WO2001028608A2/en
Publication of WO2001028608A3 publication Critical patent/WO2001028608A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/05—Stirrers
    • B01F27/11—Stirrers characterised by the configuration of the stirrers
    • B01F27/112—Stirrers characterised by the configuration of the stirrers with arms, paddles, vanes or blades
    • B01F27/1126—Stirrers characterised by the configuration of the stirrers with arms, paddles, vanes or blades the stirrer being a bent rod supported at one end only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/05—Stirrers
    • B01F27/051—Stirrers characterised by their elements, materials or mechanical properties
    • B01F27/054—Deformable stirrers, e.g. deformed by a centrifugal force applied during operation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/44—Mixers with shaking, oscillating, or vibrating mechanisms with stirrers performing an oscillatory, vibratory or shaking movement
    • B01F31/445—Mixers with shaking, oscillating, or vibrating mechanisms with stirrers performing an oscillatory, vibratory or shaking movement performing an oscillatory movement about an axis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/65—Mixers with shaking, oscillating, or vibrating mechanisms the materials to be mixed being directly submitted to a pulsating movement, e.g. by means of an oscillating piston or air column
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/65—Mixers with shaking, oscillating, or vibrating mechanisms the materials to be mixed being directly submitted to a pulsating movement, e.g. by means of an oscillating piston or air column
    • B01F31/651—Mixing by successively aspirating a part of the mixture in a conduit, e.g. a piston, and reinjecting it through the same conduit into the receptacle
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/45—Magnetic mixers; Mixers with magnetically driven stirrers
    • B01F33/452—Magnetic mixers; Mixers with magnetically driven stirrers using independent floating stirring elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/45—Magnetic mixers; Mixers with magnetically driven stirrers
    • B01F33/453—Magnetic mixers; Mixers with magnetically driven stirrers using supported or suspended stirring elements
    • B01F33/4534—Magnetic mixers; Mixers with magnetically driven stirrers using supported or suspended stirring elements using a rod for supporting the stirring element, e.g. stirrer sliding on a rod or mounted on a rod sliding in a tube
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/30—Driving arrangements; Transmissions; Couplings; Brakes
    • B01F35/32—Driving arrangements
    • B01F35/32005—Type of drive
    • B01F35/32025—Battery driven
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B15/00—Details of spraying plant or spraying apparatus not otherwise provided for; Accessories
    • B05B15/20—Arrangements for agitating the material to be sprayed, e.g. for stirring, mixing or homogenising
    • B05B15/25—Arrangements for agitating the material to be sprayed, e.g. for stirring, mixing or homogenising using moving elements, e.g. rotating blades
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0266—Shape memory materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8275—Mechanical
    • A61M2205/8281—Mechanical spring operated

Definitions

  • This invention relates to a medicament dispenser including an agitator for agitating the medicament contents thereof.
  • the dispenser is particularly suitable for use as an inhalation device.
  • Known medicament dispensers comprise a medicament container having a dispensing outlet for dispensing of the medicament therefrom. Such medicament dispensers often require the patient to agitate the contents thereof prior to dispensing to ensure ready and uniform dispensing of the medicament. The agitation involves a manual shaking action.
  • the dispenser comprises medicament as a suspension in a propellant formulation.
  • a well-known example of this type is the metered dose inhaler for dispensing of respiratory medicament which comprises an aerosol container having a dispensing valve.
  • the medicament is comprised within the aerosol container in the form of a suspension comprising propellant and optionally other additives such as solvents or surfactants.
  • Such suspensions have a tendency to settle out, sediment or cream.
  • a pre- dispensing agitation step is necessary to re-establish a uniform suspension so that uniform dispensing of medicament may be achieved.
  • Agitation can also be required where the medicament is in powder form. It is known that powders can tend to settle out, agglomerate or even cake on storage. The agitation therefore performs the function of breaking up any agglomerates or cakes that may have formed, and thereby ensures that the powder is readily dispensable.
  • PCT Patent Application No. WO95/30607 describes a metered dose dispensing valve including a movable agitator in the metering chamber. Manual shaking of the valve causes movement of the agitator therein which is stated to assist mixing of the drug suspension in the metering chamber.
  • PCT Patent Application No. WO96/08284 describes an inhalation device for dispensing powder form medicament including a movable weight which is configured to strike an anvil upon manual shaking of the device. The striking action causes a jolt which acts such as to assist transfer of the powder from a reservoir container to a metering recess formed in a dosing member.
  • the Applicants have now developed a medicament dispenser which requires little or no manual shaking.
  • the dispenser comprises a medicament container and an agitator for agitating the contents of the medicament container.
  • a drive is provided for driving the agitator independently of any movement of the container.
  • the dispenser therefore provides for agitation of the medicament container and contents thereof without requiring shaking by the patient.
  • a medicament dispenser comprising a medicament container having a dispensing outlet; an agitator for agitating the contents of the container; and a driver for driving the agitator independently of any movement of the container.
  • the agitator comprises a movable element within said container. More preferably, the movable element is freely movable within the container.
  • the movable element is magnetically coupled to the driver.
  • the movable element or the driver comprises magnetic material or material which is magnetically inductive, that is to say material into which magnetism can be induced.
  • the material may be . permanently or non-permanently magnetisable.
  • the movable element is mechanically coupled to the driver.
  • the container includes a rim defining an access hole
  • the movable element comprises a flexible sheath protruding through said access hole
  • the driver comprises a rod insertable within said flexible sheath for agitation thereof.
  • the flexible sheath is in sealing contact with the rim.
  • the movable element is pneumatically drivable.
  • the movable element is hydraulically drivable.
  • the movable element is electrically drivable.
  • the movable element comprises a multi-component strip or wire which is deformable in response to electrical current flow.
  • Suitable multi-component strips typically comprise a plurality of layers of material, each material having a different coefficient of thermal expansion.
  • multi-component strips include strips comprising multiple layers of different metals (e.g. bimetallic strips) and strips comprising at least one piezoelectric or piezoresistive material.
  • Suitable piezoelectric materials include piezoelectric ceramics, such as compounds of lead zirconate and lead titanate, and piezoelectric crystals which are generally polycrystalline ferroelectric materials with the perovskite structure.
  • Suitable multi-component wires typically comprise alloys of two or more metals wherein one or more of the metals undergoes a temperature induced phase change in response to electrical current flow.
  • Preferred examples of multi- component wires include those comprised of alloys of titanium and nickel which contract when electric current is applied.
  • the movable element is shaped to create turbulence within the container when agitated.
  • the agitator creates regions of pressure difference within the container.
  • the agitator comprises a piston mechanism within the container. More preferably, the piston mechanism is mechanically drivable by the driver. Most preferably, the drive comprises a plunger for moving the piston.
  • the agitator provides wave energy to the interior of the container. Preferably, the agitator is an acoustic wave energy generator or a resonant wave energy generator.
  • the driver is associable with the container.
  • the driver may be external to, or internal to, the container and may be permanently or reversibly attached to the container.
  • the medicament dispenser additionally comprises a housing.
  • the driver is associable with the housing.
  • the driver may be external to, or internal to, the housing and may be permanently or reversibly attached to the housing.
  • the driver comprises an energy store for storing energy which energy is releasable to drive the agitator.
  • the energy store comprises a biasable resilient member.
  • the biasable resilient member is a spring.
  • the energy store comprises a clockwork mechanism.
  • the energy store comprises a battery.
  • the driver is responsive to a patient-actuable trigger.
  • the trigger may comprise a button, switch or lever arrangement. More preferably, the trigger comprises a sensor which senses the breath of a patient.
  • the senor comprises a breath-movable element which is movable in response to the breath of a patient.
  • the breath-movable element is selected from the group consisting of a vane, a sail, a piston and an impeller.
  • the senor comprises a pressure sensor for sensing the pressure profile associated with the breath of a patient.
  • the senor comprises an airflow sensor for sensing the airflow profile associated with the breath of a patient.
  • the senor comprises a temperature sensor for sensing the temperature profile associated with the breath of a patient.
  • the senor comprises a moisture sensor for sensing the moisture profile associated with the breath of a patient.
  • the senor comprises a gas sensor for sensing the oxygen or carbon dioxide profile associated with the breath of a patient.
  • dispensing from the dispensing outlet is responsive to a second patient-actuable trigger.
  • the patient-actuable triggers are coupled such that agitation and dispensing occurs in a sequential fashion.
  • the container is an aerosol container, preferably comprising a metering valve at the dispensing outlet.
  • the aerosol container comprises a suspension of a medicament in a propellant.
  • the propellant preferably comprises liquefied HFA134a, HFA-227 or carbon dioxide.
  • the medicament is preferably selected from the group consisting of albuterol, salmeterol, fluticasone propionate, beclomethasone dipropionate, salts or solvates thereof and any mixtures thereof.
  • Figure 1 is a cut-away perspective view of a first medicament dispenser in accord with the present invention
  • Figure 2 is a sectional view of a second medicament dispenser in accord with the present invention.
  • Figure 3 is a sectional view of a third medicament dispenser in accord with the present invention.
  • Figures 4a and 4b are sectional views of a fourth medicament dispenser in accord with the present invention.
  • FIG. 1 shows a medicament dispenser suitable for use in a metered dose inhaler (MDI) for delivery of inhalable medicament.
  • the dispenser comprises an aerosol can 10 having a dispenser outlet in the form of a metering valve 12.
  • the valve gasket 14 is fixedly attached (typically by crimping) to the aerosol can body 10.
  • the can 10 comprises a suspension 20 of medicament in a propellant.
  • Within the can 10 there are provided four vibratable flippers 30 mounted on cross-mounting 32.
  • Each vibratable flipper 30 is comprised of a bimetallic strip which flexes on application of electrical current. In alternative embodiments, the flippers may also comprise piezoelectric materials.
  • the cross-mounting 32, and hence each flipper 30, is connected to external electric power source 40 which may be in the form of a battery or a capacitor. On application of electric power the flippers 30 vibrate thereby resulting in agitation of the suspension 20.
  • Figure 2. also shows a medicament dispenser suitable for use in a metered dose inhaler (MDI) for delivery of inhalable medicament.
  • the dispenser comprises an aerosol can 110 having a dispenser outlet in the form of a metering valve 112.
  • the valve gasket 114 is fixedly attached (typically by crimping) to the aerosol can body 110.
  • the can 110 comprises a suspension 120 of medicament in a propellant.
  • an access hole 116 is provided in the base 118 of the aerosol can 110 for receipt of flexible elongate sheath 132.
  • the sheath 132 typically comprises a latex, rubber or elastomeric material and may be seen to protrude well into the interior of the can 110.
  • drive rod 130 which comprises a resiliently flexible material.
  • the drive rod 130 connects to drive motor 140 which may for example, be an electric or clockwork motor.
  • the drive motor 140 may in embodiments be configured to provide oscillatory or rotatory drive motion to the drive rod 130. On application of the drive energy the drive rod 130 moves within the sheath 132 thereby resulting in agitation of the suspension 120.
  • the electric or clockwork drive motor 140 is replaced by a mechanical push-drive which is capable of translating a push motion (e.g. at the top 142 of the drive) into a rotatory drive motion.
  • a push-drive could incorporate a suitably configured gear train or worm and helix drive mechanism.
  • the dispensing action typically requires the user to push down on the base 118 of the can 110 such that the valve 112 is released.
  • the use of the push-drive will facilitate a agitation- dispensing sequence in which a first user pushing action on the push-drive results in agitation of the suspension 120 and a second user pushing action (which may be a continuation of the first) results in dispensing of the suspension 120.
  • FIG. 3 shows a further medicament dispenser suitable for use in a metered dose inhaler (MDI) for delivery of inhalable medicament.
  • the dispenser comprises an aerosol can 210 having a dispenser outlet in the form of a metering valve 212.
  • the valve gasket 214 is fixedly attached (typically by crimping) to the aerosol can body 210.
  • the can 210 comprises a suspension 220 of medicament in a propellant.
  • an access hole 216 is provided in the base 218 of the aerosol can 210 for receipt of dynamic seal 232.
  • the dynamic seal 232 typically comprises a rigid elastomeric material and may be seen to form a liner to the access hole 216.
  • piston drive shaft 230 Protruding through the dynamic seal 232 there is provided piston drive shaft 230.
  • Piston drive shaft 230 has a shaped plunger head 234 which may in embodiments, be connected to a drive motor (not shown) such as an electric or clockwork motor.
  • Piston 236 is received by cylinder 250 within which it is drivable. It may be seen that cylinder 250 includes entry hole 252 and narrows at its lower end to form tube 254 having exit hole 256.
  • Agitation of the suspension 220 within the can 210 is achieved by a driving movement of the piston 236 within the cylinder 250.
  • gas may enter cylinder 250 through entry hole 252.
  • the piston 236 is moved downwards the gas is initially trapped in the cylinder 250, then pushed through tube 254 and finally expelled through exit hole 256. Expulsion of the gas results in formation of bubbles 222 and flow agitation in the suspension 220.
  • Figure 4a shows a medicament dispenser suitable for use in a metered dose inhaler for delivery of inhalable medicament.
  • the dispenser comprises an aerosol canister 310 having a dispenser outlet 312 in the form of a metering valve.
  • the canister 310 has an external 315 and internal 317 wall with cavity 319 therebetween.
  • a suspension 320 of a medicament in a propellant is contained within internal wall 317 of the canister.
  • a magnetic impeller 365 is located within canister 310 and is free to rotate around axis 333 on shaft 335.
  • an electric or clockwork motor 340 which connects via drive shaft 330 to magnet 360.
  • the electric motor may be powered by any suitable means, such as a battery (not shown).
  • the magnet 360 may be rotated or oscillated on arm 331 , connecting to drive shaft 330, around internal wall 317 when powered by the motor 340. It may be appreciated that rotation or oscillation of arm 331 and of magnet 360 will result in rotation or oscillation of magnetic impeller 365.
  • the motor 340 is actuated by means of a pressure switch (not shown) to rotate drive shaft 330 and arm 331 , thereby rotating magnet 360 within cavity 319.
  • the magnet 360 on arm 331 acts magnetically on the magnetic impeller 365 within the can 310 such that the impeller 365 is also rotated. Rotation of the magnetic impeller 365 agitates the suspension 320.
  • Figure 4b shows a variation of the dispenser of Figure 4a.
  • an aerosol canister 310 is located within housing 370 such that dispenser outlet 312 is positioned within passage 377 of support 375.
  • a second passage 378 is provided within support 375 and is directed towards the interior of outlet 379.
  • Aerosol canister 310 contains a suspension 320 of a medicament in a propellant.
  • Magnetic impeller 365 is located within canister 310 and is free to rotate on shaft 335 about axis 333.
  • Detachable cap 380 encloses aerosol canister 310 within housing 370.
  • the cylindrical housing 370 divides into an internal 371 and external 372 wall with cavity 373 therebetween.
  • magnet 360 is suspended from arm 331 , connected to drive shaft 330, and is free to rotate or oscillate within the cavity 373 when powered by electric or clockwise motor 340. It will be appreciated that rotation of magnet 360 leads to rotation of magnetic impeller 365 and thus agitation of suspension 320.
  • cap 380 is compressed thereby activating a pressure switch (not shown) of motor 340 leading to rotation of magnet 360 within cavity 373. Magnetic impeller 365 is thus rotated within canister 310 and agitates suspension 320. Further compression of cap 380 pushes drive shaft 330 against canister block 311 , stopping rotation of the drive shaft and moving canister 310 relative to valve member 312. This action opens the valve and a dose of medicament contained within the aerosol canister is dispensed through passage 378 into outlet 379 to be inhaled by the patient. On removal of the pressure, resilient material 381 returns cap 380 to its resting position.
  • any of the parts of the dispenser which contact the medicament suspension may be coated with materials such as fluoropolymer materials which reduce the tendency of medicament to adhere thereto.
  • Any movable parts may also have coatings applied thereto which enhance their desired movement characteristics. Frictional coatings may therefore be applied to enhance frictional contact and lubricants used to reduce frictional contact as necessary.
  • the medicament dispenser of the invention is suitable for dispensing medicament, particularly for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease.
  • Appropriate medicaments may thus be selected from, for example, analgesics, e.g., codeine, dihydromorphine, ergotamine, fentanyl or morphine; anginal preparations, e.g., diltiazem; antiallergics, e.g., cromoglycate (e.g. s the sodium salt), ketotifen or nedocromil (e.g.
  • antiinfectives e.g., cephalosporins, penicillins, streptomycin, sulphonamides, tetracyclines and pentamidine
  • antihistamines e.g., methapyrilene
  • anti- inflammatories e.g., beclomethasone (e.g. as the dipropionate ester), fluticasone (e.g. as the propionate ester), flunisolide, budesonide, rofleponide, mometasone e.g. as the furoate ester), ciclesonide, triamcinolone (e.g.
  • antitussives e.g., noscapine
  • bronchodilators e.g., albuterol (e.g. as free base or sulphate), salmeterol (e.g. as xinafoate), ephedrine, adrenaline, fenoterol (e.g. as hydrobromide), formoterol (e.g.
  • bromide as bromide
  • tiotropium as bromide
  • atropine or oxitropium hormones, e.g., cortisone, hydrocortisone or prednisolone
  • xanthines e.g., aminophylline, choline theophyllinate, lysine theophyllinate or theophylline
  • therapeutic proteins and peptides e.g., insulin or glucagon
  • vaccines diagnostics and gene therapies.
  • the medicaments may be used in the form of salts, (e.g., as alkali metal or amine salts or as acid addition salts) or as esters (e.g., lower alkyl esters) or as solvates (e.g., hydrates) to optimise the activity and/or stability of the medicament and/or to minimise the solubility of the medicament in the propellant.
  • Preferred medicaments are selected from albuterol, salmeterol, fluticasone propionate and beclomethasone dipropionate and salts or solvates thereof, e.g., the sulphate of albuterol and the xinafoate of salmeterol.
  • Medicaments can also be delivered in combinations.
  • Preferred formulations containing combinations of active ingredients contain salbutamol (e.g., as the free base or the sulphate salt) or salmeterol (e.g., as the xinafoate salt) or formoterol (e.g. as the fumarate salt) in combination with an antiinflammatory steroid such as a beclomethasone ester (e.g., the dipropionate) or a fluticasone ester (e.g., the propionate) or budesonide.
  • a particularly preferred combination is a combination of fluticasone propionate and salmeterol, or a salt thereof (particularly the xinafoate salt).
  • a further combination of particular interest is budesonide and formoterol (e.g. as the fumarate salt).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Confectionery (AREA)
  • Valve Device For Special Equipments (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

There is provided a medicament dispenser comprising a medicament container (310) having a dispensing outlet (312); an agitator (365) for agitating the contents of the container (310); and a driver (340) for driving the agitator (365) independently of any movement of the container (310). The medicament dispenser can be a metered dose inhaler for delivery of inhalable medicament.

Description

Medicament dispenser
Technical Field
This invention relates to a medicament dispenser including an agitator for agitating the medicament contents thereof. The dispenser is particularly suitable for use as an inhalation device.
Background to the Invention
Known medicament dispensers comprise a medicament container having a dispensing outlet for dispensing of the medicament therefrom. Such medicament dispensers often require the patient to agitate the contents thereof prior to dispensing to ensure ready and uniform dispensing of the medicament. The agitation involves a manual shaking action.
Agitation is particularly required where the dispenser comprises medicament as a suspension in a propellant formulation. A well-known example of this type is the metered dose inhaler for dispensing of respiratory medicament which comprises an aerosol container having a dispensing valve. The medicament is comprised within the aerosol container in the form of a suspension comprising propellant and optionally other additives such as solvents or surfactants. Such suspensions have a tendency to settle out, sediment or cream. A pre- dispensing agitation step is necessary to re-establish a uniform suspension so that uniform dispensing of medicament may be achieved. Agitation can also be required where the medicament is in powder form. It is known that powders can tend to settle out, agglomerate or even cake on storage. The agitation therefore performs the function of breaking up any agglomerates or cakes that may have formed, and thereby ensures that the powder is readily dispensable.
Various suggestions have been made to enhance manual shaking action to maximise the effect of agitation.
PCT Patent Application No. WO95/30607 describes a metered dose dispensing valve including a movable agitator in the metering chamber. Manual shaking of the valve causes movement of the agitator therein which is stated to assist mixing of the drug suspension in the metering chamber.
PCT Patent Application No. WO96/08284 describes an inhalation device for dispensing powder form medicament including a movable weight which is configured to strike an anvil upon manual shaking of the device. The striking action causes a jolt which acts such as to assist transfer of the powder from a reservoir container to a metering recess formed in a dosing member.
Whilst manual shaking is a generally effective means for providing agitation it is sometimes inconvenient for the patient. In social situations, the patient often wishes to administer their medicament discretely and without drawing attention to themselves. Manual shaking of the dispenser is difficult to perform in a discrete fashion. This can lead to patient embarrassment. There is also always the possibility that the patient forgets to shake the dispenser, or does so inadequately, thereby affecting the medicament dose deliverable.
The Applicants have now developed a medicament dispenser which requires little or no manual shaking. The dispenser comprises a medicament container and an agitator for agitating the contents of the medicament container. A drive is provided for driving the agitator independently of any movement of the container. The dispenser therefore provides for agitation of the medicament container and contents thereof without requiring shaking by the patient.
Summary of Invention
According to one aspect of the present invention there is provided a medicament dispenser comprising a medicament container having a dispensing outlet; an agitator for agitating the contents of the container; and a driver for driving the agitator independently of any movement of the container.
Preferably, the agitator comprises a movable element within said container. More preferably, the movable element is freely movable within the container.
In one aspect, the movable element is magnetically coupled to the driver. Preferably, either or both of the movable element or the driver comprises magnetic material or material which is magnetically inductive, that is to say material into which magnetism can be induced. The material may be . permanently or non-permanently magnetisable.
in another aspect, the movable element is mechanically coupled to the driver.
In a preferred aspect, the container includes a rim defining an access hole, the movable element comprises a flexible sheath protruding through said access hole, and the driver comprises a rod insertable within said flexible sheath for agitation thereof. Preferably, the flexible sheath is in sealing contact with the rim. In another aspect, the movable element is pneumatically drivable.
In another aspect, the movable element is hydraulically drivable.
In another aspect, the movable element is electrically drivable. Preferably, the movable element comprises a multi-component strip or wire which is deformable in response to electrical current flow.
Suitable multi-component strips typically comprise a plurality of layers of material, each material having a different coefficient of thermal expansion.
Preferred examples of multi-component strips include strips comprising multiple layers of different metals (e.g. bimetallic strips) and strips comprising at least one piezoelectric or piezoresistive material. Suitable piezoelectric materials include piezoelectric ceramics, such as compounds of lead zirconate and lead titanate, and piezoelectric crystals which are generally polycrystalline ferroelectric materials with the perovskite structure.
Suitable multi-component wires typically comprise alloys of two or more metals wherein one or more of the metals undergoes a temperature induced phase change in response to electrical current flow. Preferred examples of multi- component wires include those comprised of alloys of titanium and nickel which contract when electric current is applied.
Preferably, the movable element is shaped to create turbulence within the container when agitated.
In one aspect, the agitator creates regions of pressure difference within the container. Preferably, the agitator comprises a piston mechanism within the container. More preferably, the piston mechanism is mechanically drivable by the driver. Most preferably, the drive comprises a plunger for moving the piston. In another aspect, the agitator provides wave energy to the interior of the container. Preferably, the agitator is an acoustic wave energy generator or a resonant wave energy generator.
In one aspect, the driver is associable with the container. The driver may be external to, or internal to, the container and may be permanently or reversibly attached to the container.
In another aspect, the medicament dispenser additionally comprises a housing.
Preferably the driver is associable with the housing. The driver may be external to, or internal to, the housing and may be permanently or reversibly attached to the housing.
Preferably, the driver comprises an energy store for storing energy which energy is releasable to drive the agitator.
In one aspect, the energy store comprises a biasable resilient member. Preferably, the biasable resilient member is a spring.
In another aspect, the energy store comprises a clockwork mechanism.
In another aspect, the energy store comprises a battery.
Preferably, the driver is responsive to a patient-actuable trigger. The trigger may comprise a button, switch or lever arrangement. More preferably, the trigger comprises a sensor which senses the breath of a patient.
In one aspect, the sensor comprises a breath-movable element which is movable in response to the breath of a patient. Preferably, the breath-movable element is selected from the group consisting of a vane, a sail, a piston and an impeller.
In another aspect, the sensor comprises a pressure sensor for sensing the pressure profile associated with the breath of a patient.
In another aspect, the sensor comprises an airflow sensor for sensing the airflow profile associated with the breath of a patient.
In another aspect, the sensor comprises a temperature sensor for sensing the temperature profile associated with the breath of a patient.
In another aspect, the sensor comprises a moisture sensor for sensing the moisture profile associated with the breath of a patient.
In another aspect, the sensor comprises a gas sensor for sensing the oxygen or carbon dioxide profile associated with the breath of a patient.
Preferably, dispensing from the dispensing outlet is responsive to a second patient-actuable trigger. More preferably, the patient-actuable triggers are coupled such that agitation and dispensing occurs in a sequential fashion.
In one preferred aspect, the container is an aerosol container, preferably comprising a metering valve at the dispensing outlet. Preferably, the aerosol container comprises a suspension of a medicament in a propellant.
The propellant preferably comprises liquefied HFA134a, HFA-227 or carbon dioxide. The medicament is preferably selected from the group consisting of albuterol, salmeterol, fluticasone propionate, beclomethasone dipropionate, salts or solvates thereof and any mixtures thereof.
Brief Description of the Invention
The invention will now be described further with reference to the accompanying drawings in which:
Figure 1 is a cut-away perspective view of a first medicament dispenser in accord with the present invention;
Figure 2 is a sectional view of a second medicament dispenser in accord with the present invention;
Figure 3 is a sectional view of a third medicament dispenser in accord with the present invention;
Figures 4a and 4b are sectional views of a fourth medicament dispenser in accord with the present invention;
Detailed Description of the Invention
Figure 1. shows a medicament dispenser suitable for use in a metered dose inhaler (MDI) for delivery of inhalable medicament. The dispenser comprises an aerosol can 10 having a dispenser outlet in the form of a metering valve 12. The valve gasket 14 is fixedly attached (typically by crimping) to the aerosol can body 10. The can 10 comprises a suspension 20 of medicament in a propellant. Within the can 10 there are provided four vibratable flippers 30 mounted on cross-mounting 32. Each vibratable flipper 30 is comprised of a bimetallic strip which flexes on application of electrical current. In alternative embodiments, the flippers may also comprise piezoelectric materials. The cross-mounting 32, and hence each flipper 30, is connected to external electric power source 40 which may be in the form of a battery or a capacitor. On application of electric power the flippers 30 vibrate thereby resulting in agitation of the suspension 20.
Figure 2. also shows a medicament dispenser suitable for use in a metered dose inhaler (MDI) for delivery of inhalable medicament. The dispenser comprises an aerosol can 110 having a dispenser outlet in the form of a metering valve 112. The valve gasket 114 is fixedly attached (typically by crimping) to the aerosol can body 110. The can 110 comprises a suspension 120 of medicament in a propellant.
It may be seen that an access hole 116 is provided in the base 118 of the aerosol can 110 for receipt of flexible elongate sheath 132. The sheath 132 typically comprises a latex, rubber or elastomeric material and may be seen to protrude well into the interior of the can 110. Within the sheath 132 there is provided drive rod 130 which comprises a resiliently flexible material. The drive rod 130 connects to drive motor 140 which may for example, be an electric or clockwork motor. The drive motor 140 may in embodiments be configured to provide oscillatory or rotatory drive motion to the drive rod 130. On application of the drive energy the drive rod 130 moves within the sheath 132 thereby resulting in agitation of the suspension 120.
In an alternative embodiment, the electric or clockwork drive motor 140 is replaced by a mechanical push-drive which is capable of translating a push motion (e.g. at the top 142 of the drive) into a rotatory drive motion. Such a push-drive could incorporate a suitably configured gear train or worm and helix drive mechanism. In known metered dose inhalers wherein the can 110 sits within an actuator housing, the dispensing action typically requires the user to push down on the base 118 of the can 110 such that the valve 112 is released. It may be appreciated that the use of the push-drive will facilitate a agitation- dispensing sequence in which a first user pushing action on the push-drive results in agitation of the suspension 120 and a second user pushing action (which may be a continuation of the first) results in dispensing of the suspension 120.
Figure 3. shows a further medicament dispenser suitable for use in a metered dose inhaler (MDI) for delivery of inhalable medicament. The dispenser comprises an aerosol can 210 having a dispenser outlet in the form of a metering valve 212. The valve gasket 214 is fixedly attached (typically by crimping) to the aerosol can body 210. The can 210 comprises a suspension 220 of medicament in a propellant.
It may be seen that an access hole 216 is provided in the base 218 of the aerosol can 210 for receipt of dynamic seal 232. The dynamic seal 232 typically comprises a rigid elastomeric material and may be seen to form a liner to the access hole 216. Protruding through the dynamic seal 232 there is provided piston drive shaft 230. Piston drive shaft 230 has a shaped plunger head 234 which may in embodiments, be connected to a drive motor (not shown) such as an electric or clockwork motor. Piston 236 is received by cylinder 250 within which it is drivable. It may be seen that cylinder 250 includes entry hole 252 and narrows at its lower end to form tube 254 having exit hole 256.
Agitation of the suspension 220 within the can 210 is achieved by a driving movement of the piston 236 within the cylinder 250. In more detail, it can be seen that when the piston 236 is in the withdrawn position (as shown in Figure 3) gas may enter cylinder 250 through entry hole 252. As the piston 236 is moved downwards the gas is initially trapped in the cylinder 250, then pushed through tube 254 and finally expelled through exit hole 256. Expulsion of the gas results in formation of bubbles 222 and flow agitation in the suspension 220.
Figure 4a shows a medicament dispenser suitable for use in a metered dose inhaler for delivery of inhalable medicament. The dispenser comprises an aerosol canister 310 having a dispenser outlet 312 in the form of a metering valve. The canister 310 has an external 315 and internal 317 wall with cavity 319 therebetween. A suspension 320 of a medicament in a propellant is contained within internal wall 317 of the canister. A magnetic impeller 365 is located within canister 310 and is free to rotate around axis 333 on shaft 335.
Within cavity 319 there is provided an electric or clockwork motor 340 which connects via drive shaft 330 to magnet 360. The electric motor may be powered by any suitable means, such as a battery (not shown). The magnet 360 may be rotated or oscillated on arm 331 , connecting to drive shaft 330, around internal wall 317 when powered by the motor 340. It may be appreciated that rotation or oscillation of arm 331 and of magnet 360 will result in rotation or oscillation of magnetic impeller 365.
Agitation of the suspension 320 within the aerosol canister 310 is achievable by the following steps. The motor 340 is actuated by means of a pressure switch (not shown) to rotate drive shaft 330 and arm 331 , thereby rotating magnet 360 within cavity 319. The magnet 360 on arm 331 acts magnetically on the magnetic impeller 365 within the can 310 such that the impeller 365 is also rotated. Rotation of the magnetic impeller 365 agitates the suspension 320.
Figure 4b shows a variation of the dispenser of Figure 4a. In the metered dose inhalation device of Figure 4b an aerosol canister 310 is located within housing 370 such that dispenser outlet 312 is positioned within passage 377 of support 375. A second passage 378 is provided within support 375 and is directed towards the interior of outlet 379.
Aerosol canister 310 contains a suspension 320 of a medicament in a propellant. Magnetic impeller 365 is located within canister 310 and is free to rotate on shaft 335 about axis 333. Detachable cap 380 encloses aerosol canister 310 within housing 370. The cylindrical housing 370 divides into an internal 371 and external 372 wall with cavity 373 therebetween. In the position shown, magnet 360 is suspended from arm 331 , connected to drive shaft 330, and is free to rotate or oscillate within the cavity 373 when powered by electric or clockwise motor 340. It will be appreciated that rotation of magnet 360 leads to rotation of magnetic impeller 365 and thus agitation of suspension 320.
To use the device, cap 380 is compressed thereby activating a pressure switch (not shown) of motor 340 leading to rotation of magnet 360 within cavity 373. Magnetic impeller 365 is thus rotated within canister 310 and agitates suspension 320. Further compression of cap 380 pushes drive shaft 330 against canister block 311 , stopping rotation of the drive shaft and moving canister 310 relative to valve member 312. This action opens the valve and a dose of medicament contained within the aerosol canister is dispensed through passage 378 into outlet 379 to be inhaled by the patient. On removal of the pressure, resilient material 381 returns cap 380 to its resting position.
It may be appreciated that any of the parts of the dispenser which contact the medicament suspension may be coated with materials such as fluoropolymer materials which reduce the tendency of medicament to adhere thereto. Any movable parts may also have coatings applied thereto which enhance their desired movement characteristics. Frictional coatings may therefore be applied to enhance frictional contact and lubricants used to reduce frictional contact as necessary.
The medicament dispenser of the invention is suitable for dispensing medicament, particularly for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease. Appropriate medicaments may thus be selected from, for example, analgesics, e.g., codeine, dihydromorphine, ergotamine, fentanyl or morphine; anginal preparations, e.g., diltiazem; antiallergics, e.g., cromoglycate (e.g. s the sodium salt), ketotifen or nedocromil (e.g. as the sodium salt); antiinfectives e.g., cephalosporins, penicillins, streptomycin, sulphonamides, tetracyclines and pentamidine; antihistamines, e.g., methapyrilene; anti- inflammatories, e.g., beclomethasone (e.g. as the dipropionate ester), fluticasone (e.g. as the propionate ester), flunisolide, budesonide, rofleponide, mometasone e.g. as the furoate ester), ciclesonide, triamcinolone (e.g. as the acetonide) or 6α, 9α-difluoro-11 β- hydroxy-16α-methyl-3-oxo-17α-propionyloxy-androsta-1 ,4-diene-17β-carbothioic acid S-(2-oxo-tetrahydro-furan-3-yl) ester; antitussives, e.g., noscapine; bronchodilators, e.g., albuterol (e.g. as free base or sulphate), salmeterol (e.g. as xinafoate), ephedrine, adrenaline, fenoterol (e.g. as hydrobromide), formoterol (e.g. as fumarate), isoprenaline, metaproterenol, phenylephrine, phenylpropanolamine, pirbuterol (e.g. as acetate), reproterol (e.g. as hydrochlohde), rimiterol, terbutaline (e.g. as sulphate), isoetharine, tulobuterol or 4-hydroxy-7-[2-[[2-[[3-(2-phenylethoxy)propyl]sulfonyl]ethyl]amino]ethyl-2(3H)- benzothiazolone; adenosine 2a agonists, e.g. 2R,3R,4S,5R)-2-[6-Amino-2-(1 S- hydroxymethyl-2-phenyl-ethylamino)-puhn-9-yl]-5-(2-ethyl-2H-tetrazol-5-yl)- tetrahydro-furan-3,4-diol (e.g. as maleate); α.4 integ n inhibitors e.g. (2S)-3-[4- ({[4-(aminocarbonyl)-1-piperidinyl] carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2- (2-methylphenoxy) acetyl]amino}pentanoyl)amino] propanoic acid (e.g. as free acid or potassium salt), diuretics, e.g., amiloride; anticholinergics, e.g., ipratropium (e.g. as bromide), tiotropium, atropine or oxitropium; hormones, e.g., cortisone, hydrocortisone or prednisolone; xanthines, e.g., aminophylline, choline theophyllinate, lysine theophyllinate or theophylline; therapeutic proteins and peptides, e.g., insulin or glucagon; vaccines, diagnostics and gene therapies. It will be clear to a person skilled in the art that, where appropriate, the medicaments may be used in the form of salts, (e.g., as alkali metal or amine salts or as acid addition salts) or as esters (e.g., lower alkyl esters) or as solvates (e.g., hydrates) to optimise the activity and/or stability of the medicament and/or to minimise the solubility of the medicament in the propellant. Preferred medicaments are selected from albuterol, salmeterol, fluticasone propionate and beclomethasone dipropionate and salts or solvates thereof, e.g., the sulphate of albuterol and the xinafoate of salmeterol.
Medicaments can also be delivered in combinations. Preferred formulations containing combinations of active ingredients contain salbutamol (e.g., as the free base or the sulphate salt) or salmeterol (e.g., as the xinafoate salt) or formoterol (e.g. as the fumarate salt) in combination with an antiinflammatory steroid such as a beclomethasone ester (e.g., the dipropionate) or a fluticasone ester (e.g., the propionate) or budesonide. A particularly preferred combination is a combination of fluticasone propionate and salmeterol, or a salt thereof (particularly the xinafoate salt). A further combination of particular interest is budesonide and formoterol (e.g. as the fumarate salt).
It will be understood that the present disclosure is for the purpose of illustration only and the invention extends to modifications, variations and improvements thereto.
The application of which this description and claims form part may be used as a basis for priority in respect of any subsequent application. The claims of such subsequent application may be directed to any feature or combination of features described therein. They may take the form of product, method or use claims and may include, by way of example and without limitation, one or more of the following claims:

Claims

Claims
1. A medicament dispenser comprising
a medicament container having a dispensing outlet;
an agitator for agitating the contents of the container; and
a driver for driving said agitator independently of any movement of the container.
2. A medicament dispenser according to claim 1 , wherein the agitator comprises a movable element within said container.
3. A medicament dispenser according to claim 2, wherein the movable element is freely movable within the container.
4. A medicament dispenser according to claim 2, wherein the movable element is magnetically coupled to the driver.
5. A medicament dispenser according to claim 4, wherein either or both of the movable element or the driver comprises magnetic material or material which is magnetically inductive.
6. A medicament dispenser according to claim 3, wherein the movable element is mechanically coupled to the driver.
7. A medicament dispenser according to either of claims 3 or 6, wherein the container includes a rim defining an access hole, the movable element comprises a flexible sheath protruding through said access hole, and the driver comprises a rod insertable within said flexible sheath for agitation thereof.
8. A medicament dispenser according to claim 7, wherein the flexible sheath is in sealing contact with the rim.
9. A medicament dispenser according to claim 2, wherein the movable element is pneumatically drivable.
10. A medicament dispenser according to claim 2, wherein the movable element is hydraulically drivable.
11. A medicament dispenser according to claim 2, wherein the movable element is electrically drivable.
12. A medicament dispenser according to claim 11 , wherein the movable element comprises a multi-component strip or wire which is deformable in response to electrical current flow.
13. A medicament dispenser according to claim 12, wherein said multi- component strip or wire comprises multiple layers of different metals.
14. A medicament dispenser according to claim 13, wherein the multi- component strip comprises a bimetallic strip.
15. A medicament dispenser according to either of claims 12 or 13, wherein the multi-component strip comprises at least one piezoelectric or piezoresistive material.
16. A medicament dispenser according to claim 15, wherein said multi- component wire comprises a nickel-titanium alloy.
17. A medicament dispenser according to any of claims 2 to 16, wherein the movable element is shaped to create turbulence within the container when agitated.
18. A medicament dispenser according to claim 1 , wherein the agitator creates regions of pressure difference within the container.
19. A medicament dispenser according to claim 18, wherein the agitator comprises a piston mechanism within the container.
20. A medicament dispenser according to claim 19, wherein the piston mechanism is mechanically drivable by the driver.
21. A medicament dispenser according to claim 20, wherein the drive comprises a plunger for moving the piston.
22. A medicament dispenser according to claim 18, wherein the agitator provides wave energy to the interior of the container.
23. A medicament dispenser according to claim 22, wherein the agitator is an acoustic wave energy generator.
24. A medicament dispenser according to claim 22, wherein the agitator is a resonant wave energy generator.
25. A medicament dispenser according to any of claims 1 to 24, wherein the driver is associable with the container.
26. A medicament dispenser according to any of claims 1 to 5, additionally comprising a housing.
27. A medicament dispenser according to claim 26, wherein the driver is associable with said housing.
28. A medicament dispenser according to any of claims 1 to 27, wherein the driver comprises an energy store for storing energy which energy is releasable to drive the agitator.
29. A medicament dispenser according to claim 28, wherein said energy store comprises a biasable resilient member.
30. A medicament dispenser according to claim 29, wherein said biasable resilient member is a spring.
31 . A medicament dispenser according to any of claims 28 to 30, wherein the energy store comprises a clockwork mechanism.
32. A medicament dispenser according to claim 28, wherein the energy store comprises a battery.
33. A medicament dispenser according to any of claims 1 to 32, wherein the driver is responsive to a patient-actuable trigger.
34. A medicament dispenser according to claim 33, wherein said trigger comprises a button, switch or lever arrangement.
35. A medicament dispenser according to claim 33, wherein the trigger comprises a sensor which senses the breath of a patient.
36. A medicament dispenser according to claim 35, wherein said sensor comprises a breath-movable element which is movable in response to the breath of a patient.
.37. A medicament dispenser according to claim 36, wherein said breath- movable element is selected from the group consisting of a vane, a sail, a piston and an impeller.
38. A medicament dispenser according to claim 35, wherein the sensor comprises a pressure sensor for sensing the pressure profile associated with the breath of a patient.
39. A medicament dispenser according to claim 35, wherein the sensor comprises an airflow sensor for sensing the airflow profile associated with the breath of a patient.
40. A medicament dispenser according to claim 35, wherein the sensor comprises a temperature sensor for sensing the temperature profile associated with the breath of a patient.
41. A medicament dispenser according to claim 35, wherein the sensor comprises a moisture sensor for sensing the moisture profile associated with the breath of a patient.
42. A medicament dispenser according to claim 35, wherein the sensor comprises a gas sensor for sensing the oxygen or carbon dioxide profile associated with the breath of a patient.
43. A medicament dispenser according to any of claims 33 to 42, wherein dispensing from the dispensing outlet is responsive to a second patient-actuable trigger.
44. A medicament dispenser according to claim 43, wherein the patient- actuable triggers are coupled such that agitation and dispensing occurs in a sequential fashion.
45. A medicament dispenser according to any of claims 1 to 44, wherein said container is an aerosol container.
46. A medicament dispenser according to claim 45, comprising a metering valve at the dispensing outlet.
47. A medicament dispenser according to either of claims 45 or 46, wherein said aerosol container comprises a suspension of a medicament in a propellant.
48. A medicament dispenser according to claim 47, wherein said propellant comprises liquefied HFA134a, HFA-227 or carbon dioxide.
49. A medicament dispenser according to either of claims 47 or 48, wherein the medicament is selected from the group consisting of albuterol, salmeterol, fluticasone propionate, beclomethasone dipropionate, salts or solvates thereof and any mixtures thereof.
PCT/EP2000/009641 1999-10-21 2000-09-28 Medicament dispenser Ceased WO2001028608A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT00966101T ATE462461T1 (en) 1999-10-21 2000-09-28 DISPENSING DEVICE FOR MEDICINAL PRODUCTS
DE60044091T DE60044091D1 (en) 1999-10-21 2000-09-28 DISPOSABLE DEVICE FOR MEDICINAL PRODUCTS
JP2001531436A JP2003512099A (en) 1999-10-21 2000-09-28 Pharmaceutical dispenser
EP00966101A EP1221990B1 (en) 1999-10-21 2000-09-28 Medicament dispenser
US10/110,957 US7185648B1 (en) 1999-10-21 2000-09-28 Medicament dispenser
AU76612/00A AU7661200A (en) 1999-10-21 2000-09-28 Medicament dispenser

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924808.0A GB9924808D0 (en) 1999-10-21 1999-10-21 Medicament dispenser
GB9924808.0 1999-10-21

Publications (2)

Publication Number Publication Date
WO2001028608A2 true WO2001028608A2 (en) 2001-04-26
WO2001028608A3 WO2001028608A3 (en) 2001-11-01

Family

ID=10863050

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009641 Ceased WO2001028608A2 (en) 1999-10-21 2000-09-28 Medicament dispenser

Country Status (8)

Country Link
US (1) US7185648B1 (en)
EP (1) EP1221990B1 (en)
JP (1) JP2003512099A (en)
AT (1) ATE462461T1 (en)
AU (1) AU7661200A (en)
DE (1) DE60044091D1 (en)
GB (1) GB9924808D0 (en)
WO (1) WO2001028608A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007017482A1 (en) * 2005-08-08 2007-02-15 Novartis Ag Insulated canister for metered dose inhalers
WO2008144089A1 (en) 2007-02-22 2008-11-27 New Brunswick Scientific Company, Inc. Torsionally flexible sealed drive
EP2272583A1 (en) * 2001-02-06 2011-01-12 Levtech Inc. Apparatus and method for mixing materials sealed in a container under sterile conditions
US7926482B2 (en) 2004-04-27 2011-04-19 Consort Medical Plc Dispensing apparatus
USRE43418E1 (en) 2003-10-14 2012-05-29 Atmi Bvba Flexible mixing bag for mixing solids, liquids, and gases
WO2017102495A1 (en) * 2015-12-17 2017-06-22 Ksb Aktiengesellschaft Arrangement for intermixing
US10335562B2 (en) 2006-07-24 2019-07-02 3M Innovative Properties Company Metered dose dispensers with porous body
CN110809484A (en) * 2017-06-29 2020-02-18 阿森迪斯药物股份有限公司 Autoinjector with reconstitution handling support
US10632433B2 (en) 2006-05-13 2020-04-28 Pall Life Sciences Belgium Bvba Disposable bioreactor
WO2023167918A3 (en) * 2022-03-01 2023-10-12 Sartorius Stedim Biotech Gmbh Containers including internal mixers and methods of use

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924780D0 (en) 1999-10-21 1999-12-22 Glaxo Group Ltd Medicament dispenser
GB0016123D0 (en) * 2000-07-01 2000-08-23 Glaxo Group Ltd Valve for aerosol container
AU2002952683A0 (en) * 2002-11-15 2002-11-28 Commonwealth Scientific And Industrial Research Organisation Apparatus for delivering dry aerosols to the respiratory tract
WO2005012140A1 (en) * 2003-07-28 2005-02-10 Bryan James Larkin A spray applicator
GB0620700D0 (en) * 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
US20100300437A1 (en) * 2007-05-10 2010-12-02 Sivigny Michael B Manufacture of metered dose valve components
US8857429B2 (en) * 2007-06-15 2014-10-14 Idtx Systems, Inc. Drug delivery and monitoring system for a ventilator
GB0819220D0 (en) * 2008-10-21 2008-11-26 Laliberte Jean Charles Automatic food dispenser
WO2010105991A1 (en) * 2009-03-20 2010-09-23 Livia Tiba Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
FR2946537B1 (en) * 2009-06-11 2012-08-03 Valois Sas INHALATION DEVICE FOR POWDER
FR2946538B1 (en) * 2009-06-11 2012-08-03 Valois Sas INHALATION DEVICE FOR POWDER
US8920364B2 (en) 2013-02-28 2014-12-30 Medtronic Xomed, Inc. Biomaterial delivery device
US8845578B2 (en) 2013-02-28 2014-09-30 Medtronic Xomed, Inc. Biomaterial delivery device
US8807131B1 (en) 2013-06-18 2014-08-19 Isonea Limited Compliance monitoring for asthma inhalers
US10092888B2 (en) * 2014-11-07 2018-10-09 Genesis Technologies, Llc Linear reciprocating actuator
US10561814B2 (en) 2014-11-19 2020-02-18 Idtx Systems, Inc. Automated drug dispensing systems with automated HME bypass for ventilator circuits
CN104758056B (en) * 2015-02-04 2018-08-17 深圳市罗伯医疗科技有限公司 A kind of fluid delivery system and surgery device
US20180056022A1 (en) * 2015-03-21 2018-03-01 James Zhou Liu Hand-actuated dry powder inhaler and its use
US10869502B2 (en) * 2015-07-31 2020-12-22 14Th Round Inc. Disposable assembly for vaporizing e-liquid and a method of using the same
EP3370810B1 (en) * 2015-11-06 2019-12-18 Boehringer Ingelheim International GmbH System with nebulizer and container
EP3241608B1 (en) * 2016-05-02 2020-04-08 Levitronix GmbH Mixing device and disposable device for such a mixing device
DE102016013773B4 (en) * 2016-11-18 2023-09-07 Pieter Van Weenen & Co. Gmbh The House Of Innovation Devices and methods for aerosol exposure
KR102019593B1 (en) * 2018-03-06 2019-09-06 주식회사 케이티앤지 Aerosol inhaler
KR102016848B1 (en) * 2018-03-06 2019-08-30 주식회사 케이티앤지 Cartridge for use of smoking article and aerosol inhaler thereof
KR102019595B1 (en) * 2018-03-07 2019-09-06 주식회사 케이티앤지 Tobacco material inhaler
WO2020215028A1 (en) * 2019-04-18 2020-10-22 Jon Greenfield Positive pressure inhaler for delivery of inhalable medication and methods for use
CN111166978A (en) * 2020-01-22 2020-05-19 山东医学高等专科学校 Otolaryngology clinical medicine device that spouts with adjustable
CN111569204A (en) * 2020-05-27 2020-08-25 苗世敏 Disposable oxygen atomizing inhaler for pediatrics
CN111778092B (en) * 2020-07-27 2022-05-20 重庆合晶能源科技有限公司 Magnetic lubricating oil and preparation method thereof
CN112044304B (en) * 2020-08-07 2022-03-22 张颖玮 Mixing arrangement is used in production of diabetic nephropathy treatment medicine
GB202014292D0 (en) 2020-09-11 2020-10-28 Kindeva Drug Delivery Lp Apparatus for agitation of medicament formulation
KR102254604B1 (en) * 2020-12-08 2021-05-21 권이성 Dispenser for powder-type toothpaste
US11607508B1 (en) * 2020-12-23 2023-03-21 Stat Capsule Inc. Device for sublingual application of a therapeutic dose of medication in fractions
CN112808363A (en) * 2020-12-30 2021-05-18 复信(江苏)环境科技有限公司 Preparation method and device of heavy metal remover for soil remediation
GB2607273A (en) * 2021-04-29 2022-12-07 3D Engineering Design Ltd Inhaler

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030607A1 (en) 1994-05-06 1995-11-16 Minnesota Mining And Manufacturing Company Metered dose aerosol valve with agitator
WO1996008284A2 (en) 1994-09-16 1996-03-21 Laboratoire Glaxo Wellcome Inhalation device

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877994A (en) 1954-05-03 1959-03-17 Harold D Jones Sealing devices for use with rotary or oscillatory shafts
US3042310A (en) * 1960-11-23 1962-07-03 Reinhold A Franke Hand paint spray gun agitator
GB997088A (en) * 1963-06-14 1965-06-30 Alger Marcus Lynn Improvements relating to spraying devices
US3384354A (en) * 1966-07-05 1968-05-21 Gattys Tech Agitator device
US3456644A (en) 1967-01-19 1969-07-22 Dart Ind Inc Inhalation-actuated aerosol dispensing device
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
US3636949A (en) 1969-08-08 1972-01-25 Armstrong Kropp Dev Corp Inhalation-initiated aerosol dispenser
BE758834A (en) 1969-11-13 1971-05-12 Riker Laboratoires Inc AEROSOL DISPENSER ACTIVATED BY INHALATION
GB1383761A (en) 1971-02-25 1974-02-12 Woodcraft Dc Inhalation device for use with an aerosol container
US3863903A (en) * 1974-01-11 1975-02-04 Stewart Warner Corp Agitator assembly for mixing paint
US3971377A (en) 1974-06-10 1976-07-27 Alza Corporation Medicament dispensing process for inhalation therapy
YU41046B (en) 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
US4061315A (en) 1976-06-16 1977-12-06 American Hospital Supply Corporation Orbital platform stirring system
US4259021A (en) * 1978-04-19 1981-03-31 Paul R. Goudy, Jr. Fluid mixing apparatus and method
US4184778A (en) * 1979-03-12 1980-01-22 Terrels Joseph L Cup for paint sprayer
IT1167734B (en) 1980-04-18 1987-05-13 Beckman Instruments Inc PROCEDURE AND MIXING EQUIPMENT USING AN AUTOMATED PIPETTE
US4518103A (en) * 1981-09-09 1985-05-21 Aerosol Services Co. Method and apparatus for releasing additional ingredients in a pressurized container
US4502342A (en) 1982-02-16 1985-03-05 Templeton Coal Company, Inc. Pulsed drive means for shaker
GB2129322A (en) 1982-10-22 1984-05-16 Patrick Joseph Kemple Detachable stirring device
US4612291A (en) 1984-09-04 1986-09-16 American Monitor Corporation Method and apparatus for mixing serum and reagents for chemical analysis
US4648393A (en) 1984-11-02 1987-03-10 Ackrad Laboratories, Inc. Breath activated medication spray
JPS61217431A (en) * 1985-03-20 1986-09-27 Kobe Steel Ltd Powder exhaust method and device from container
US4759635A (en) 1985-08-08 1988-07-26 Techne Corporation Magnetic stirrer apparatus with improved stirring action
CH667437A5 (en) * 1985-12-06 1988-10-14 Intecser Sa DEVICE SUITABLE TO KEEP SEPARATE IN A CONTAINER, UNTIL THE TIME OF USE AND THEN TO MIX THEM IMMEDIATELY BEFORE DISPENSING THEM, TWO DIFFERENT SUBSTANCES, IN PARTICULAR RESIN WITH TWO COMPONENTS.
DE3545614A1 (en) * 1985-12-21 1987-06-25 Hilti Ag COMBINED CARTRIDGE FOR TWO-COMPONENT SIZES
EP0401060B1 (en) 1989-05-31 1993-06-30 Conceptair Anstalt Method and electrical, electronic and mechanical device for dispensing, metering or diffusing liquid or gaseous aromas, medicines and other liquid or viscous product
US5071040A (en) * 1990-03-09 1991-12-10 Pfizer Hospital Products Group, Inc. Surgical adhesives mixing and dispensing implement
GB9015077D0 (en) 1990-07-09 1990-08-29 Riker Laboratories Inc Inhaler
US5027808A (en) 1990-10-31 1991-07-02 Tenax Corporation Breath-activated inhalation device
NZ241034A (en) * 1990-12-17 1995-03-28 Minnesota Mining & Mfg Inhaler device with a dosage control that deactivates an aerosol generator after predetermined time or dosage
DE4193534T1 (en) 1991-04-15 1997-07-24 Leiras Oy Device for metering a dose of powdered medicament for inhalation
JP3135605B2 (en) 1991-06-10 2001-02-19 株式会社東芝 Stir bar
US6029661A (en) 1991-08-26 2000-02-29 3M Innovative Properties Company Powder dispenser
EP0617610B1 (en) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB2262452B (en) * 1991-12-19 1995-12-20 Minnesota Mining & Mfg Inhalation device
DE4216252C2 (en) * 1992-05-16 1994-05-26 Albrecht Konietzko Arrangement with a stirrer for mixing pharmaceutical and / or cosmetic ointments, pastes, creams, jellies or emulsions
US5352036A (en) 1992-09-23 1994-10-04 Habley Medical Technology Corporation Method for mixing and dispensing a liquid pharmaceutical with a miscible component
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
AU684494B2 (en) * 1993-03-06 1997-12-18 Stephen James Rowland Atomisation of liquids
US5608693A (en) 1993-05-07 1997-03-04 Richards; Jeffrey Non-linear vibration device
JP3553599B2 (en) * 1993-06-29 2004-08-11 インジェット ディジタル エアロソルズ リミテッド dispenser
SE9400335D0 (en) 1994-02-02 1994-02-02 Astra Ab Powder mixing
US5451105A (en) 1994-07-27 1995-09-19 Koering; Herman J. Self-supporting apparatus for repeatedly agitating an aerosol canister
US5879081A (en) * 1995-01-09 1999-03-09 Chordia; Lalit M. Mixing apparatus having self-sealing spring-loaded seals
US5622166A (en) 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
US5842786A (en) * 1997-03-07 1998-12-01 Solomon; Alan Method and device for mixing medical compositions
GB2334461B (en) * 1998-02-20 2002-01-23 Bespak Plc Inhalation apparatus
GB9805938D0 (en) * 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
US6378518B1 (en) * 1998-10-30 2002-04-30 Richard George Miekka Method for producing uniform small doses of finely divided substances
US6116234A (en) 1999-02-01 2000-09-12 Iep Pharmaceutical Devices Inc. Metered dose inhaler agitator
US6293693B1 (en) * 1999-04-14 2001-09-25 Mentor Corporation Method and apparatus for sanitary mixing of viscous materials
AU777169B2 (en) * 1999-04-23 2004-10-07 Battelle Memorial Institute High mass transfer electrosprayer
US6474563B2 (en) * 2000-05-03 2002-11-05 Sarnoff Corporation Spraying device for dispensing home care formulations with electrostatic liquid droplets
US6387077B1 (en) 2000-10-13 2002-05-14 Mallinckrodt Inc. Apparatus and method for providing a suspended agent
JP4832661B2 (en) * 2000-10-17 2011-12-07 株式会社ダイゾー Rotating aerosol products
JP3619176B2 (en) * 2001-09-14 2005-02-09 オムロンヘルスケア株式会社 Aerosol particle sorting device and inhaler

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030607A1 (en) 1994-05-06 1995-11-16 Minnesota Mining And Manufacturing Company Metered dose aerosol valve with agitator
WO1996008284A2 (en) 1994-09-16 1996-03-21 Laboratoire Glaxo Wellcome Inhalation device

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272583A1 (en) * 2001-02-06 2011-01-12 Levtech Inc. Apparatus and method for mixing materials sealed in a container under sterile conditions
USRE43418E1 (en) 2003-10-14 2012-05-29 Atmi Bvba Flexible mixing bag for mixing solids, liquids, and gases
US7926482B2 (en) 2004-04-27 2011-04-19 Consort Medical Plc Dispensing apparatus
AU2006277929B2 (en) * 2005-08-08 2010-07-15 Novartis Ag Insulated canister for metered dose inhalers
WO2007017482A1 (en) * 2005-08-08 2007-02-15 Novartis Ag Insulated canister for metered dose inhalers
CN101238047B (en) * 2005-08-08 2010-06-16 诺瓦提斯公司 Insulated cartridges for metered dose inhalers
US10632433B2 (en) 2006-05-13 2020-04-28 Pall Life Sciences Belgium Bvba Disposable bioreactor
US10335562B2 (en) 2006-07-24 2019-07-02 3M Innovative Properties Company Metered dose dispensers with porous body
WO2008144089A1 (en) 2007-02-22 2008-11-27 New Brunswick Scientific Company, Inc. Torsionally flexible sealed drive
EP2121896A4 (en) * 2007-02-22 2013-11-13 New Brunswick Scientific Co VIBRATION-FLEXIBLE AND SEALED DRIVE
US8794821B2 (en) 2007-02-22 2014-08-05 Eppendorf, Inc. Torsionally flexible, sealed drive
WO2017102495A1 (en) * 2015-12-17 2017-06-22 Ksb Aktiengesellschaft Arrangement for intermixing
CN110809484A (en) * 2017-06-29 2020-02-18 阿森迪斯药物股份有限公司 Autoinjector with reconstitution handling support
WO2023167918A3 (en) * 2022-03-01 2023-10-12 Sartorius Stedim Biotech Gmbh Containers including internal mixers and methods of use

Also Published As

Publication number Publication date
ATE462461T1 (en) 2010-04-15
JP2003512099A (en) 2003-04-02
GB9924808D0 (en) 1999-12-22
WO2001028608A3 (en) 2001-11-01
EP1221990A2 (en) 2002-07-17
DE60044091D1 (en) 2010-05-12
US7185648B1 (en) 2007-03-06
EP1221990B1 (en) 2010-03-31
AU7661200A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
US7185648B1 (en) Medicament dispenser
US7461650B1 (en) Medicament dispenser
US8240301B2 (en) Dispensing device
CA2293487C (en) Dispenser with doses counter
EP1326669B1 (en) Inhaler
EP1292348B1 (en) Medicament dispenser
EP1395320B1 (en) Medicament dispenser
EP1379305B1 (en) Medicament dispenser
US20050251289A1 (en) Medicament dispenser
US20050268908A1 (en) Medicament dispenser
US20050274378A1 (en) Medicament dispenser
WO2002017998A1 (en) Inhalation device
EP1159020A1 (en) Medicament delivery system
WO2002087489A1 (en) Medicament dispenser
MXPA99011407A (en) Dispenser with doses'counter
MXPA99011403A (en) Dispenser with doses counter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000966101

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10110957

Country of ref document: US

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 531436

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000966101

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642